Published Technical Disclosure Archive

AI-Powered Immunoisolation Membrane for Advanced Transplantation

Publication ID: 24-11856946_0005_PTD
Published: October 26, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “AI-Powered Immunoisolation Membrane for Advanced Transplantation,” Published Technical Disclosure No. 24-11856946_0005_PTD, Published October 26, 2025, available at https://archive.pr1or.art/24-11856946_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,856,946.

Background and Problem Solved

The original patent disclosed a chamber for transplantation with a membrane for immunoisolation, but it had limitations in terms of scalability, adaptability, and integration with artificial components. The new invention addresses these limitations by introducing adaptive membranes, AI-powered monitoring, and hybrid organ-chamber designs, enabling more effective and personalized transplantation.

Novelty and Inventive Step

The new invention's adaptive membrane, AI-powered monitoring system, and hybrid organ-chamber design represent a significant departure from the original patent's static membrane and limited scalability. These features provide a more effective, personalized, and scalable solution for transplantation, making the original invention obsolete.

Alternative Embodiments and Variations

Alternative embodiments of the invention could include different materials and geometries for the adaptive membrane, various AI algorithms for the monitoring system, and diverse hybrid organ-chamber designs for specific applications. Additionally, the invention could be adapted for use in other fields, such as tissue engineering or biofabrication.

Potential Commercial Applications and Market

The invention has significant commercial potential in the fields of regenerative medicine, personalized transplantation, and large-scale biological constituent production. Target industries include pharmaceuticals, biotechnology, and medical devices, with potential applications in organ transplantation, tissue engineering, and biofabrication.

CPC Classifications

SectionClassGroup
A A01 A01N1/0231
B B01 B01D63/089
A A61 A61B2017/00969

Field of Art

Regenerative medicine, biomedical engineering, and immunoisolation technologies focusing on cell and tissue transplantation systems with selective membranes

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or biotech researcher with advanced degrees in bioengineering, expertise in membrane technologies, immunology, and transplantation techniques, familiar with materials science and adaptive biomedical design principles

Obviousness Rationale

A PHOSITA would recognize that the PTD's variations represent predictable extensions of the source patent's core immunoisolation membrane technology, utilizing standard engineering approaches to enhance functionality through adaptive materials, AI monitoring, and modular design strategies that are well-established in biomedical engineering practice.

Obvious Combinations & Variations

Source Patent Element
Porous polymer membrane for immunoisolation in transplantation chamber
PTD Variation
Dynamic, self-healing membrane capable of adapting to biological constituent size and shape
Obviousness Reasoning
Known polymer engineering techniques enable responsive membrane materials with shape memory and self-healing properties, representing a predictable optimization of existing membrane technologies
Source Patent Element
Fixed membrane design with standard immunoisolation properties
PTD Variation
AI-powered monitoring system tracking biological constituent health and adjusting membrane permeability
Obviousness Reasoning
Integration of sensor technologies and adaptive control systems is a standard engineering approach for improving medical device performance, with well-understood implementation strategies
Source Patent Element
Transplantation chamber with limited scalability
PTD Variation
Modular, scalable bioreactor design with replaceable membrane components
Obviousness Reasoning
Modular design principles are common in biomedical engineering, representing an obvious solution to improve manufacturing flexibility and device adaptability
Source Patent Element
Basic transplantation chamber for biological constituents
PTD Variation
Hybrid organ-chamber integrating artificial organ components with immunoisolation membrane
Obviousness Reasoning
Combining artificial and biological components is a known approach in regenerative medicine, representing a predictable technological evolution with finite design solutions
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11856946, a Person Having Ordinary Skill In The Art would find the claimed variations in the present publication to be obvious extensions of existing immunoisolation membrane technologies, representing predictable combinations of known techniques in biomedical engineering that would be apparent to a skilled practitioner without requiring inventive insight.

Original Patent Information

Patent NumberUS 11,856,946
TitleChamber for transplantation and device for transplantation
Assignee(s)FUJI ELECTRIC CO., LTD.